Standout Papers

Causality assessment of adverse reactions to drugs—I. A novel method based on the con... 1990 2026 2002 2014 1.1k
  1. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries (1993)
    Gaby Danan, C Bénichou Journal of Clinical Epidemiology
  2. Criteria of drug-induced liver disorders (1990)
    C Bénichou Journal of Hepatology

Citation Impact

Citing Papers

Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
2014
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
1992
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
2015
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
2012
Incidence of drug-induced liver injury in medical inpatients
2005
Thiazolidinediones
2004 Standout
Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms
2014
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb
2011
Drug-induced liver diseases
2000
Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective
1995
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Burden of liver diseases in the world
2018 Standout
Adverse drug reactions: definitions, diagnosis, and management
2000 Standout
Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products
2007
Individual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and Perforation
1997 Standout
Under-Reporting of Adverse Drug Reactions
2006 Standout
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
2001
The use of SAMe in chemotherapy-induced liver injury
2018
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
2011
Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
2008 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Eighteen cases of liver injury following ingestion of Polygonum multiflorum
2013
Herbal hepatotoxicity
2005
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
Antibiotic therapy: a major cause of drug-induced jaundice in southwest England
2007
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
2013
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
2016
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The Medical Dictionary for Regulatory Activities (MedDRA)
1999 Standout
Pancreatic Adenocarcinoma
2014 Standout
Procalcitonine et méningites virales : réduction des traitements antibiotiques inutiles par le dosage en routine au cours d’une épidémie
2002
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Detection and incidence of drug‐induced liver injuries in hospital: a prospective analysis from laboratory signals
2000
Herbal Hepatotoxicity
2007
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences
2018
International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*
2005 Standout
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps
2015
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections
1999
Hepatotoxicity from green tea: a review of the literature and two unpublished cases
2009
Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis
1997
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Drug-Related Adverse Events
2001
Microfluidic organs-on-chips
2014 Standout
Childhood encephalopathy: viruses, immune response, and outcome
2006
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Herbal hepatotoxicity: Challenges and pitfalls of causality assessment methods
2013
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
HLA association of amoxicillin-clavulanate–induced hepatitis
1999
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study
2010 Standout
Incidence of drug-induced hepatic injuries: A French population-based study
2002
Idiosyncratic drug hepatotoxicity
2005
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
2001
The ChEMBL database in 2017
2016 Standout
Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults
2010 Standout
Review article: drug hepatotoxicity
2007
The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention
2010 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Risk of Pancreatic Adenocarcinoma in Patients With Hereditary Pancreatitis: A National Exhaustive Series
2008
Reliability of a Modified Medication Appropriateness Index in Ambulatory Older Persons
1997
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study
2001
Acute and clinically relevant drug‐induced liver injury: a population based case‐control study
2004
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis
2002
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic
2006
Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality
2010
Trastuzumab-Induced Hepatotoxicity: A Case Report
2013 Standout
Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review
2014 Standout
The role of non-steroidal anti-inflammatory drugs in acute liver injury.
1992
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Kava hepatotoxicity. A clinical review
2010
Fulminant Hepatic Failure Associated with Propylthiouracil
2003
Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials
2002
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Causality classification at pharmacovigilance centres in the european community
1992
The medical dictionary for drug regulatory affairs (MEDDRA) project
1994
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
2007
Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management
2017
Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy
2017
Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem
2014 Standout
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Interaction between Fenofibrate and Warfarin
1998
Investigation of Correlation Among Safety Biomarkers in Serum, Histopathological Examination, and Toxicogenomics
2011
Challenges in Systematic Reviews That Assess Treatment Harms
2005
Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial
2016
Oral Aloe Vera-Induced Hepatitis
2007
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Interactions of Warfarin with Drugs and Food
1994
Aloe-induced Toxic Hepatitis
2010
Drug-induced liver disease
2000
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Hepatitis associated with terbinafine therapy: three case reports and a review of the literature
1998
Fatal hepatitis after herbal tea
1992
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
2019 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Drug‐induced acute liver failure in children and adults: Results of a single‐centre study of 128 patients
2017

Works of C Bénichou being referenced

Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
1993 Standout
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993
Absence of Intrathecal Synthesis of Some Interferon-  Subtypes in Bacterial Meningitis
1992
[How to diagnose a cutaneous complication of a drug. Application to vascular purpura].
1987
Towards an adverse drug reactions dictionary. Should existing terminologies be harmonized?
1993
[Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
1989
Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
1991
Experts' Opinion in Causality Assessment: Results of Consensus Meetings
1991
[Drug-induced hemolytic anemia. Results of consensus conferences].
1988
Criteria of drug-induced liver disorders
1990 Standout
[Drug-induced renal insufficiency. Results of consensus meetings].
1989
Adverse Drug Reactions: A Practical Guide to Diagnosis and Management
1994
EEC Pharmacovigilance and the Pharmaceutical Industry: Common Market, Common Rules?
1992
[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
1987
[Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].
1989
Rankless by CCL
2026